# Study of Oxycyte in Severe Closed Head Injury

> **NCT00174980** · PHASE2 · TERMINATED · sponsor: **Tenax Therapeutics, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Oxycyte

## Key facts

- **NCT ID:** NCT00174980
- **Lead sponsor:** Tenax Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2008-03
- **Final completion:** 2008-04
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174980, "Study of Oxycyte in Severe Closed Head Injury". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00174980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*